Close Menu

layoffs

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The past year saw several high-profile firms in the genomics tools and molecular diagnostics industries undertake restructurings and/or layoffs amid challenging economic conditions.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – SQI Diagnostics announced after the close of the market on Wednesday that it is restructuring its business to focus on its Diagnostics Tools and Services business.

Qiagen reported after the close of the market Monday that it will cut between 8 percent and 10 percent of its global workforce in a reorganization intended to improve efficiency and resource allocation.

Thermo Fisher Scientific has reduced its headcount by about 890 through the first nine months of the year, including 450 during the third quarter, it disclosed in it quarterly earnings document filed today with the US Securities and Exchange Commission.

This story was originally published Oct. 26.

Illumina filed a document with the US Securities and Exchange Commission disclosing that it will cut 200 jobs from its global workforce.

Pages

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.